Acute Heart Failure Clinical Trial
Official title:
Investigating All-Cause 30-Day Hospital Readmisisons in Patients Discharged From a Tertiary Teaching Hospital With Acute Decompensated Heart Failure Diagnosis
Verified date | August 2019 |
Source | The Methodist Hospital System |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a dissertation study which is divided into three different studies in order to answer
the main research question (Study 3). The primary aim of this research (dissertation) is to
investigate all-cause 30-day hospital readmission using functional mobility (5mWT, 30STS,
6MWT, TUG), psychosocial attributes (KCCQ-12, HADS, ESSI), adherence to home exercise
program, participation in a supervised exercise program, and number of follow up checkups
with physicians or advanced health providers of patients with Acute Decompensated Heart
Failure (ADHF) diagnosis who were discharged from a tertiary teaching hospital.
Study 1: What is the effect of acute physical therapy on functional ability in individuals
admitted with ADHF? Study 2: What is the effect of acute physical therapy on psychosocial
attributes in individuals admitted with ADHF? Study 3: Which factors such as functional
mobility (5mWT, 30STS, 6MWT, TUG), psychosocial attributes (KCCQ-12, HADS, ESSI), adherence
to home exercise program, participation in a supervised exercise program, and number of
follow up checkups with physicians or advanced health providers predict all-cause 30-day
hospital readmission in patients discharged from a tertiary, teaching hospital with ADHF
diagnosis?
Status | Completed |
Enrollment | 102 |
Est. completion date | August 28, 2019 |
Est. primary completion date | January 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - all admitted at Houston Methodist Hospital with a primary diagnosis of acute heart failure or similar type of medical diagnosis - stable medical state (HR equal or greater than 50 bpm, mean BP of 60 mmHg or better, Oxygen saturation (with or without oxygen supplement) of 90% or better; RR of 15 or better - 50 years old and over and able to follow 2 simple commands - establish discharge recommendation to home settings - ambulatory with or without assitive device(s) Exclusion Criteria: - history of psychiatric disorder - diagnosis of acute kidney injury requiring continuous renal replacement therapy - diagnosis of major cognitive impairment (dementia, Alzheimer's dse, etc) - inability to read and understand basic english language - establish discharge recommendation to post-acute care settings (e.g. SNF, inpatient rehab, LTACH) - inability to complete any functional mobility test due to musculoskeletal or other disorders |
Country | Name | City | State |
---|---|---|---|
United States | Houston Methodist Hospital | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
The Methodist Hospital System | Texas Woman's University |
United States,
13. Reeves GR, Whellan DJ, Duncan P, et al. Rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial: Design and rationale. Am Heart J. 2017;185:130-139. Accessed 08/17/2017. doi: http://dx.doi.org.ezp.twu.edu/10.1016/j.ahj.2016.12.012.
3. Hines AL BM, Jiang JH SC. Conditions with the largest number of adult hospital readmissions by payer, 2011: Statistical brief #172. Agency for Healthcare Research and Quality (US), Rockville (MD); 2006. http://europepmc.org/abstract/MED/24901179; https://www.ncbi.nlm.nih.gov/books/NBK206781. Accessed July 08, 2017.
Afilalo J, Eisenberg MJ, Morin JF, Bergman H, Monette J, Noiseux N, Perrault LP, Alexander KP, Langlois Y, Dendukuri N, Chamoun P, Kasparian G, Robichaud S, Gharacholou SM, Boivin JF. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010 Nov 9;56(20):1668-76. doi: 10.1016/j.jacc.2010.06.039. — View Citation
Alhurani AS, Dekker RL, Abed MA, Khalil A, Al Zaghal MH, Lee KS, Mudd-Martin G, Biddle MJ, Lennie TA, Moser DK. The association of co-morbid symptoms of depression and anxiety with all-cause mortality and cardiac rehospitalization in patients with heart failure. Psychosomatics. 2015 Jul-Aug;56(4):371-80. doi: 10.1016/j.psym.2014.05.022. Epub 2014 Jun 2. — View Citation
Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012 Jul 24;126(4):501-6. doi: 10.1161/CIRCULATIONAHA.112.125435. — View Citation
DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother. 2004 Apr;38(4):649-60. Epub 2004 Feb 24. Review. Erratum in: Ann Pharmacother. 2004 Jun;38(6):1092. — View Citation
Fisher SR, Graham JE, Ottenbacher KJ, Deer R, Ostir GV. Inpatient Walking Activity to Predict Readmission in Older Adults. Arch Phys Med Rehabil. 2016 Sep;97(9 Suppl):S226-31. doi: 10.1016/j.apmr.2015.09.029. Epub 2016 Jun 2. — View Citation
Fisher SR, Kuo YF, Sharma G, Raji MA, Kumar A, Goodwin JS, Ostir GV, Ottenbacher KJ. Mobility after hospital discharge as a marker for 30-day readmission. J Gerontol A Biol Sci Med Sci. 2013 Jul;68(7):805-10. doi: 10.1093/gerona/gls252. Epub 2012 Dec 19. — View Citation
Garrison C, Cook C. Clinimetrics corner: the Global Rating of Change Score (GRoC) poorly correlates with functional measures and is not temporally stable. J Man Manip Ther. 2012 Nov;20(4):178-81. doi: 10.1179/1066981712Z.00000000022. — View Citation
Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000 Apr;35(5):1245-55. — View Citation
Herman T, Giladi N, Hausdorff JM. Properties of the 'timed up and go' test: more than meets the eye. Gerontology. 2011;57(3):203-10. doi: 10.1159/000314963. Epub 2010 May 20. — View Citation
Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010 May 5;303(17):1716-22. doi: 10.1001/jama.2010.533. — View Citation
Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. — View Citation
Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17(3):163-70. — View Citation
McCabe N, Butler J, Dunbar SB, Higgins M, Reilly C. Six-minute walk distance predicts 30-day readmission after acute heart failure hospitalization. Heart Lung. 2017 Jul - Aug;46(4):287-292. doi: 10.1016/j.hrtlng.2017.04.001. Epub 2017 May 24. — View Citation
McIlvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. Circulation. 2015 May 19;131(20):1796-803. doi: 10.1161/CIRCULATIONAHA.114.010270. — View Citation
Mitchell PH, Powell L, Blumenthal J, Norten J, Ironson G, Pitula CR, Froelicher ES, Czajkowski S, Youngblood M, Huber M, Berkman LF. A short social support measure for patients recovering from myocardial infarction: the ENRICHD Social Support Inventory. J Cardiopulm Rehabil. 2003 Nov-Dec;23(6):398-403. — View Citation
Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, Normand SL, Schreiner G, Spertus JA, Vidán MT, Wang Y, Wang Y, Krumholz HM. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010 Jan;3(1):97-103. doi: 10.1161/CIRCHEARTFAILURE.109.885210. Epub 2009 Nov 10. — View Citation
Schmitt J, Abbott JH. Global ratings of change do not accurately reflect functional change over time in clinical practice. J Orthop Sports Phys Ther. 2015 Feb;45(2):106-11, D1-3. doi: 10.2519/jospt.2015.5247. Epub 2015 Jan 8. — View Citation
Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003 Aug 1;1:29. — View Citation
Spertus JA, Jones PG. Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):469-76. — View Citation
Stern AF. The hospital anxiety and depression scale. Occup Med (Lond). 2014 Jul;64(5):393-4. doi: 10.1093/occmed/kqu024. — View Citation
Tabata M, Shimizu R, Kamekawa D, Kato M, Kamiya K, Akiyama A, Kamada Y, Tanaka S, Noda C, Masuda T. Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failure. Int Heart J. 2014;55(4):331-6. Epub 2014 Jun 5. — View Citation
Vaglio J Jr, Conard M, Poston WS, O'Keefe J, Haddock CK, House J, Spertus JA. Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes. 2004 May 13;2:24. — View Citation
Walenkamp MM, de Muinck Keizer RJ, Goslings JC, Vos LM, Rosenwasser MP, Schep NW. The Minimum Clinically Important Difference of the Patient-rated Wrist Evaluation Score for Patients With Distal Radius Fractures. Clin Orthop Relat Res. 2015 Oct;473(10):3235-41. doi: 10.1007/s11999-015-4376-9. Epub 2015 Jun 4. Erratum in: Clin Orthop Relat Res. 2015 Sep;473(9):3063. — View Citation
Wilson CM, Kostsuca SR, Boura JA. Utilization of a 5-Meter Walk Test in Evaluating Self-selected Gait Speed during Preoperative Screening of Patients Scheduled for Cardiac Surgery. Cardiopulm Phys Ther J. 2013 Sep;24(3):36-43. — View Citation
Yamada S, Shimizu Y, Suzuki M, Izumi T; PTMaTCH collaborators. Functional limitations predict the risk of rehospitalization among patients with chronic heart failure. Circ J. 2012;76(7):1654-61. Epub 2012 Apr 7. — View Citation
* Note: There are 27 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Kansas City Cardiomyopathy Questionnaire (KCCQ) | A 23-item, self-administered subjective questionnaire, to measure the quality of life of individuals living with heart failure regarding their physical function, heart failure symptoms, social and physical function with a score of 0 to 100, where the higher the number, the better the health status. | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Other | Hospital Anxiety and Depresssion Scale (HADS) | A self-reported score measuring the level of anxiety and depression in the past week where the total score of anxiety and depression is 0 to 21, with the higher range from 8- 21 as borderline to abnormal. | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Other | Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Social Support Instrument (ESSI) | Seven item self-reported survey to measure an individual's perceived level of social support. | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Primary | hospital readmission within 30 days | Identification of patient hospital readmission within 30 days of discharge (day 0). | less than or equal to 30 days | |
Secondary | Six Minute Walk Test (6MWT) | Compare measured total walking distance (in feet) within 6 minutes time | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Secondary | 30 seconds Sit to Stand Test (30STS) | Measurement of the total number of times a patient can complete a sit to stand task within 30 seconds, using a standard chair with arm rest (quantity of tasks) | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Secondary | Five Meter Walk Test (5mWT) | Measurement of walking speed (in meter/seconds) over a 5 meter walking distance | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Secondary | Time Up and Go Test of Fall Risk (TUG) | To classify patient's risk of falls will measure the time (in seconds) it takes to complete the task of standing up from a chair, walk 10 feet, turn around, and return to previous sitting position. | Comparing any change between pre-physical therapy treatment (Day 1) to post-physical therapy treatment (defined as time frame: Day 2 to 8 weeks) | |
Secondary | Global Rating of Change Scale (GROC) | To rate a 4 question, 11 point Likert scale per question, regarding a person's perception of the change in (1) walking distance, (2) walking speed, (3) risk of falls, and (4) number of times of complete sit to stand task after completing acute physical therapy services | End of study (post-physical therapy; defined as time frame: Day 2 to 8 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02151383 -
Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure
|
Phase 2 | |
Completed |
NCT02135835 -
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
|
Phase 4 | |
Recruiting |
NCT05556044 -
Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
|
Phase 3 | |
Recruiting |
NCT04363697 -
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
|
Phase 4 | |
Completed |
NCT02122640 -
Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department
|
N/A | |
Completed |
NCT01193998 -
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
|
N/A | |
Not yet recruiting |
NCT01211886 -
Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)
|
N/A | |
Not yet recruiting |
NCT06465498 -
Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography
|
N/A | |
Recruiting |
NCT05276219 -
Optimized Treatment of Pulmonary Edema or Congestion
|
Phase 4 | |
Recruiting |
NCT05392764 -
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
|
Phase 3 | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Completed |
NCT06024889 -
Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.
|
Phase 1/Phase 2 | |
Terminated |
NCT04174794 -
Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial
|
||
Recruiting |
NCT05972746 -
Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure
|
N/A | |
Enrolling by invitation |
NCT02258984 -
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
|
N/A | |
Completed |
NCT02141607 -
Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock
|
||
Completed |
NCT01870778 -
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
|
Phase 3 | |
Recruiting |
NCT05986773 -
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
|
Phase 4 | |
Recruiting |
NCT04163588 -
Sequential Nephron Blockade in Acute Heart Failure
|
Phase 3 | |
Recruiting |
NCT04329234 -
Korean Heart Failure Registry III
|